Allergan to Buy MAP Pharmaceuticals for $958M

Jan. 22 (Bloomberg) -- Allergan agreed to pay $25 per share for MAP Pharmaceuticals in what the companies called a “definitive merger agreement.” Matt Miller reports on Bloomberg Television's "Bloomberg Rewind." (Source: Bloomberg)
Aetna to Buy Humana for $37 Billion
50:38 - Bloomberg's Francine Lacqua and Manus Cranny report on today's "Top Headlines." They speak on Bloomberg Television's "The Pulse." (Source: Bloomberg)
  • No Single Personality Can Unite Greece Now: Michaletos
  • Global Stock Market Still in Pretty Good Shape: Gilbert
  • Greek 'No' Vote Would Make Euro Exit Likely: Nakisa